FMC Corporation Announces Third Quarter Results

FMC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in millions, except per share amounts)

Three Months Ended

Nine Months Ended

September 30

September 30

2015

2014

2015

2014

Revenue

$

830.7

$

819.1

$

2,377.2

$

2,370.9

Costs of sales and services

610.4

535.6

1,600.4

1,478.3

Gross margin

220.3

283.5

776.8

892.6

Selling, general and administrative expenses

137.0

140.7

590.9

374.9

Research and development expenses

37.2

30.2

102.8

88.5

Restructuring and other charges (income)

45.6

35.6

78.2

44.9

Business separation costs

—

6.8

—

23.6

Total costs and expenses

830.2

748.9

2,372.3

2,010.2

Income (loss) from operations

0.5

70.2

4.9

360.7

Equity in (earnings) loss of affiliates

—

0.1

—

(0.2)

Interest expense, net

20.2

12.8

58.9

37.6

Income (loss) from continuing operations before income taxes

(19.7)

57.3

(54.0)

323.3

Provision (benefit) for income taxes

(25.1)

3.6

(56.4)

74.6

Income (loss) from continuing operations

5.4

53.7

2.4

248.7

Discontinued operations, net of income taxes

(5.0)

6.4

698.8

(4.9)

Net income (loss)

$

0.4

$

60.1

$

701.2

$

243.8

  Less: Net income attributable to noncontrolling interests

2.8

3.8

8.1

12.8

Net income (loss) attributable to FMC stockholders

$

(2.4)

$

56.3

$

693.1

$

231.0

Amounts attributable to FMC stockholders:

  Income (loss) from continuing operations, net of tax

$

2.6

$

51.6

$

(5.7)

$

241.1

  Discontinued operations, net of tax

(5.0)

4.7

698.8

(10.1)

  Net income (loss)

$

(2.4)

$

56.3

$

693.1

$

231.0

Basic earnings (loss) per common share attributable to FMC stockholders:

 Continuing operations

$

0.02

$

0.39

$

(0.04)

$

1.81

 Discontinued operations

(0.04)

0.03

5.22

(0.08)

 Basic earnings per common share

$

(0.02)

$

0.42

$

5.18

$

1.73

Average number of shares outstanding used in basic earnings per share computations

133.8

133.4

133.7

133.3

Diluted earnings (loss) per common share attributable to FMC stockholders:

  Continuing operations

$

0.02

$

0.39

$

(0.04)

$

1.80

  Discontinued operations

(0.04)

0.03

5.22

(0.08)

  Diluted earnings per common share

$

(0.02)

$

0.42

$

5.18

$

1.72

Average number of shares outstanding used in diluted earnings per share computations

134.4

134.3

133.7

134.3

Other Data:

Capital additions

$

31.6

$

42.0

$

76.1

$

121.1

Depreciation and amortization expense

$

38.0

$

23.0

$

92.2

$

70.9

FMC CORPORATION
SCHEDULE OF ADJUSTED EARNINGS FROM CONTINUING OPERATIONS (NON-GAAP)⁽²⁾
(Unaudited, in millions, except per share amounts)

Three Months Ended

Nine Months Ended

September 30

September 30

2015

2014

2015

2014

Revenue

$

830.7

$

819.1

$

2,377.2

$

2,370.9

Costs of sales and services

581.6

535.6

1,552.3

1,474.1

Gross margin

249.1

283.5

824.9

896.8

Selling, general and administrative expenses

117.3

102.7

345.1

330.0

Research and development expenses

37.2

30.2

102.8

88.5

Equity in (earnings) loss of affiliates

—

0.1

—

(0.2)

Total costs and expenses

736.1

668.6

2,000.2

1,892.4

Adjusted earnings from continuing operations, before interest, income taxes and noncontrolling interests (Non-GAAP) ⁽¹⁾

$

94.6

$

150.5

$

377.0

$

478.5

Interest expense, net

20.2

12.8

58.9

37.6

Adjusted earnings from continuing operations, before income taxes and noncontrolling interests

$

74.4

$

137.7

$

318.1

$

440.9

Provision for income taxes

15.2

39.2

81.1

120.8

Net income attributable to noncontrolling interests

2.8

2.1

8.1

7.6

Adjusted after-tax earnings from continuing operations, attributable to FMC stockholders (Non-GAAP) ⁽²⁾

$

56.4

$

96.4

$

228.9

$

312.5

Diluted adjusted after-tax earnings from continuing operations per share, attributable to FMC stockholders

$

0.42

$

0.72

$

1.70

$

2.33

Average number of shares outstanding used in diluted adjusted after-tax earnings from continuing operations per share computations ⁽³⁾

134.4

134.3

134.4

134.3

(1)

Referred to as Adjusted Operating Profit.

(2)

The Company believes that the Non-GAAP financial measure "Adjusted After-Tax Earnings from Continuing Operations, attributable to FMC Stockholders", and its presentation on a per share basis, provides useful information about the Company's operating results to investors . Adjusted Earnings excludes the effects of Corporate special charges, Non-GAAP tax adjustments and the results of our discontinued operations. The Company also believes that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of its underlying businesses from period to period. Additionally, the above schedule is presented in a format which reflects the manner in which we manage our business and is not in accordance with GAAP.

(3)

The average number of shares outstanding used in the nine months ended September 30, 2015 diluted adjusted after-tax earnings from continuing operations per share computation (Non-GAAP) includes 0.7 million diluted shares. This number of shares differs from the average number of shares outstanding used in diluted earnings per share computations (GAAP) as we had a net loss from continuing operations attributable to FMC stockholders.

FMC CORPORATION
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP)
TO ADJUSTED AFTER-TAX EARNINGS FROM CONTINUING OPERATIONS,
ATTRIBUTABLE TO FMC STOCKHOLDERS (NON-GAAP)
(Unaudited, in millions, except per share amounts)

Three Months Ended

Nine Months Ended

September 30

September 30

2015

2014

2015

2014

Net income (loss) attributable to FMC stockholders (GAAP)

$

(2.4)

$

56.3

$

693.1

$

231.0

Corporate special charges (income):

Restructuring and other charges (income) ^(a)

45.6

35.6

78.2

44.9

Non-operating pension and postretirement charges ^(b)

5.5

1.5

19.9

8.4

Business separation costs ^(c)

—

6.8

—

23.6

Acquisition-related charges ^(d)

43.0

36.5

274.0

40.7

Income tax expense (benefit) on Corporate special charges (income)

(13.7)

(27.7)

(113.8)

(40.8)

Discontinued operations attributable to FMC stockholders, net of income taxes ^(e)

5.0

(4.7)

(698.8)

10.1

Non-GAAP tax adjustments ^(f)

(26.6)

(7.9)

(23.7)

(5.4)

Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)

$

56.4

$

96.4

$

228.9

$

312.5

Diluted earnings per common share (GAAP)

$

(0.02)

$

0.42

$

5.18

$

1.72

Corporate special charges (income) per diluted share, before tax:

Restructuring and other charges (income)

0.34

0.27

0.58

0.34

Non-operating pension and postretirement charges

0.04

0.01

0.15

0.06

Business separation costs

—

0.05

—

0.17

Acquisition-related charges

0.32

0.27

2.04

0.30

Income tax expense (benefit) on Corporate special charges (income), per diluted share

(0.10)

(0.21)

(0.85)

(0.30)

Discontinued operations per diluted share

0.04

(0.03)

(5.22)

0.08

Non-GAAP tax adjustments per diluted share

(0.20)

(0.06)

(0.18)

(0.04)

Diluted adjusted after-tax earnings from continuing operations per share, attributable to FMC stockholders (Non-GAAP)

$

0.42

$

0.72

$

1.70

$

2.33

Average number of shares outstanding used in diluted adjusted after-tax earnings from continuing operations per share computations

134.4

134.3

134.4

134.3

(a) 

Three Months Ended September 30, 2015:

Restructuring and other charges (income) includes a charge of $50.7 million, primarily related to exit of generic crop protection business in Brazil and severance associated with the integration of Cheminova, a charge of $16.6 million associated with the reorganization of our FMC Health and Nutrition segment, of which, $11.9 million was due to the sale of our pectin manufacturing business. Remaining restructuring and charges included net miscellaneous charges of $2.0 million. Offsetting these charges was other income associated with sale of our remaining ownership interest in a Belgian-based pesticide distribution company for $26.6 million, slightly offset by charges from continuing environmental sites treated as a Corporate charge of $2.9 million.

Three Months Ended September 30, 2014:

Restructuring and other charges (income) includes a charge of $17.0 million associated with a license agreement entered into by our FMC Agricultural Solutions segment for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development. Additionally, this amount includes charges associated with continuing environmental sites treated as a Corporate charge of $17.3 million. Remaining restructuring and other charges (income) includes net miscellaneous charges of $1.3 million.

Nine Months Ended September 30, 2015:

Restructuring and other charges (income) includes a charge of $55.5 million, primarily related to exit of generic crop protection business in Brazil of $40.1 million and severance associated with the integration of Cheminova of $12.2 million, a charge of $20.5 million associated with the reorganization of our FMC Health and Nutrition segment, of which, $11.9 million was due to the sale of our pectin manufacturing business. Remaining restructuring and charges included net miscellaneous charges of $5.5 million. Offsetting these charges was other income associated with sale of our remaining ownership interest in a Belgian-based pesticide distribution company for $26.6 million, slightly offset by charges from continuing environmental sites treated as a Corporate charge of $8.3 million and a charge of $15.0 million associated with a license agreement entered into for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development both of which pertain our FMC Agricultural Solutions segment.

Nine Months Ended September 30, 2014:

Restructuring and other charges (income) includes a charge of $5.8 million associated with a reorganization of our Health and Nutrition segment, as well as a charge of $17.0 million associated a license agreement entered into by our FMC Agricultural Solutions segment for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development. Additionally, this amount includes charges associated with continuing environmental sites treated as a Corporate charge of $20.0 million. Remaining restructuring and other charges (income) includes net miscellaneous charges of $2.1 million.

(b) 

Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our Adjusted Earnings results noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.

(c) 

There were no charges for the three and nine months ended September 30, 2015. On September 8, 2014, we announced that we will no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three and nine months ended September 30, 2014 represent charges associated with the planned separation activities through September 8, 2014.

(d)

Charges related to the expensing of the inventory fair value step-up resulting from the application of acquisition accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:

Three Months Ended

Nine Months Ended

September 30

September 30

(in Millions)

2015

2014

2015

2014

Acquisition-related charges - Cheminova A/S

Legal and professional fees ⁽¹⁾

$

14.2

$

15.3

$

53.8

$

15.3

Inventory fair value amortization ⁽²⁾

28.8

—

48.1

—

Loss/(gain) on hedging purchase price ⁽¹⁾

—

21.2

172.1

21.2

Acquisition-related charges - Epax

Inventory fair value amortization ⁽²⁾

—

—

—

4.2

Acquisition-related charges

$

43.0

$

36.5

$

274.0

$

40.7

(1)

On the condensed consolidated statements of income (loss), these charges are included in "Selling, general and administrative expenses."

(2)

On the condensed consolidated statements of income (loss), these charges are included in "Costs of sales and services."

(e) 

Three and Nine Months Ended September 30, 2015

Discontinued operations includes our FMC Alkali Chemicals division as well as provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations. The nine months ended September 30, 2015 includes the divestiture gain of approximately $700 million associated with the sale of FMC Alkali Chemicals division which was completed on April 1, 2015.

Three and Nine Months Ended September 30, 2014

Discontinued operations includes our FMC Alkali and FMC Peroxygens business results as well as provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations. The nine months ended September 30, 2014 includes the final divestiture charge associated with the sale of FMC Peroxygens business which was completed on February 28, 2014.

(f) 

We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the projected annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but are not limited to: income tax expenses or benefits that are not related to ongoing business operations in the current year; unusual or infrequently occurring items; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets; and changes in tax law. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.

Three Months Ended

Nine Months Ended

September 30

September 30

(in Millions)

2015

2014

2015

2014

Non-GAAP tax adjustments:

Revisions to our tax liabilities due to finalization of prior year tax returns

$

(0.9)

$

(1.2)

$

0.1

$

(0.2)

Revisions to valuation allowances of historical deferred tax assets

—

—

7.6

—

Foreign currency remeasurement and foreign currency discrete items

(25.7)

(6.7)

(31.4)

(5.2)

Non-GAAP tax adjustments

$

(26.6)

$

(7.9)

$

(23.7)

$

(5.4)

RECONCILIATION OF NET INCOME (LOSS) (GAAP) TO ADJUSTED EARNINGS FROM CONTINUING OPERATIONS, BEFORE INTEREST AND INCOME TAXES (NON-GAAP)
(Unaudited, in millions)

Three Months Ended

Nine Months Ended

September 30

September 30

2015

2014

2015

2014

Net income (loss) (GAAP)

$

0.4

$

60.1

$

701.2

$

243.8

Restructuring and other charges (income)

45.6

35.6

78.2

44.9

Non-operating pension and postretirement charges

5.5

1.5

19.9

8.4

Business separation costs

—

6.8

—

23.6

Acquisition-related charges

43.0

36.5

274.0

40.7

Discontinued operations, net of income taxes

5.0

(6.4)

(698.8)

4.9

Interest expense, net

20.2

12.8

58.9

37.6

Provision (benefit) for income taxes

(25.1)

3.6

(56.4)

74.6

Adjusted earnings from continuing operations, before interest, income taxes and noncontrolling interests (Non-GAAP) ⁽¹⁾

$

94.6

$

150.5

$

377.0

$

478.5

(1)

     Referred to as Adjusted Operating Profit.

FMC CORPORATION
INDUSTRY SEGMENT DATA
(Unaudited, in millions)

Three Months Ended

Nine Months Ended

September 30

September 30

2015

2014

2015

2014

Revenue

FMC Agricultural Solutions

$

577.6

$

548.8

$

1,595.6

$

1,546.9

FMC Health and Nutrition

195.9

203.1

613.5

636.4

FMC Lithium

57.2

67.2

168.1

187.6

Total

$

830.7

$

819.1

$

2,377.2

$

2,370.9

Income from continuing operations before income taxes

FMC Agricultural Solutions

59.4

116.7

262.6

367.5

FMC Health and Nutrition

47.0

43.7

148.5

143.7

FMC Lithium

1.8

5.3

11.9

19.4

Segment operating profit ^(a)

108.2

165.7

423.0

530.6

Corporate and other

(13.6)

(15.2)

(46.0)

(52.1)

Adjusted earnings from continuing operations, before interest, income taxes and noncontrolling interests (Non-GAAP)

$

94.6

$

150.5

$

377.0

$

478.5

Interest expense, net

(20.2)

(12.8)

(58.9)

(37.6)

Corporate special (charges) income:

Restructuring and other (charges) income ^(b)

(45.6)

(35.6)

(78.2)

(44.9)

Non-operating pension and postretirement charges ^(c)

(5.5)

(1.5)

(19.9)

(8.4)

Business separation charges ^(d)

—

(6.8)

—

(23.6)

Acquisition-related charges ^(e)

(43.0)

(36.5)

(274.0)

(40.7)

(Provision) benefit for income taxes

25.1

(3.6)

56.4

(74.6)

Discontinued operations, net of income taxes ^(f)

(5.0)

6.4

698.8

(4.9)

Net income attributable to noncontrolling interests

(2.8)

(3.8)

(8.1)

(12.8)

Net income (loss) attributable to FMC stockholders

$

(2.4)

$

56.3

$

693.1

$

231.0

(a)

Referred to as Segment Earnings.

(b)

Below provides the details of restructuring and other charges (income) by segment.

Three Months Ended September 30

Nine Months Ended September 30

2015

2014

2015

2014

FMC Agricultural Solutions                                             

$

(24.1)

$

(17.0)

$

(47.2)

$

(17.0)

FMC Health and Nutrition

(16.6)

—

(20.6)

(5.9)

FMC Lithium

—

(0.1)

(0.5)

—

Corporate

(4.9)

(18.5)

(9.9)

(22.0)

Restructuring and other (charges) income

$

(45.6)

$

(35.6)

$

(78.2)

$

(44.9)

(c) 

See Note (b) to the schedule "Reconciliation of Net Income (Loss) Attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, Attributable to FMC Stockholders (Non-GAAP)" for further details on the components that make up this line item.

(d) 

See Note (c) to the schedule "Reconciliation of Net Income (Loss) Attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, Attributable to FMC Stockholders (Non-GAAP)" for further details on the components that make up this line item.

(e) 

See Note (d) to the schedule "Reconciliation of Net Income (Loss) Attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, Attributable to FMC Stockholders (Non-GAAP)" for further details on the components that make up this line item.

(f) 

See Note (e) to the schedule "Reconciliation of Net Income (Loss) Attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, Attributable to FMC Stockholders (Non-GAAP)" for further details on the components that make up this line item.

FMC CORPORATION
FMC AGRICULTURAL SOLUTIONS PRO FORMA FINANCIAL RESULTS
(Unaudited, in millions)

In the second quarter of 2015, we began to present pro forma combined results for the FMC Agricultural Solutions segment for 2015 and 2014. We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment for 2015 and 2014 is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of this segment. Our pro forma segment information will include adjustments as if the Cheminova transaction had occurred on January 1, 2014. Our pro forma data will also be adjusted for the effects of acquisition accounting but will not include adjustments for cost related to integration activities, cost savings or synergies that might be achieved by the combined businesses. Pro forma amounts to be presented will not necessarily be indicative of what our results would have been had we operated Cheminova since January 1, 2014, nor our future results. We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment for these interim periods is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of the segment.

FMC Agricultural Solutions Pro Forma Financial Results

Three Months Ended September 30

Nine Months Ended September 30

(in Millions)

2015

2014

2015

2014

Revenue

Revenue, FMC Agricultural Solutions, as reported ⁽¹⁾            

$

577.6

$

548.8

$

1,595.6

$

1,546.9

Revenue, Cheminova, pro forma ⁽²⁾

—

305.4

362.0

999.1

Pro Forma Combined, Revenue ⁽³⁾

$

577.6

$

854.2

$

1,957.6

$

2,546.0

Operating Profit

Operating Profit, FMC Agricultural Solutions, as reported ⁽¹⁾

$

59.4

$

116.7

$

262.6

$

367.5

Operating Profit, Cheminova, pro forma ⁽²⁾

—

(1.4)

19.9

58.1

Pro Forma Combined, Operating Profit ⁽³⁾

$

59.4

$

115.3

$

282.5

$

425.6

(1)

As reported amounts are the results of operations of FMC Agricultural Solutions, including the results of the Cheminova acquisition from April 21, 2015 onward.

(2)

Cheminova pro forma amounts include the historical results of Cheminova, prior to April 21, 2015. These amounts also include adjustments as if the Cheminova transaction had occurred on January 1, 2014, including the effects of acquisition accounting. The pro forma amounts do not include adjustments for expenses related to integration activities, cost savings or synergies that may have been or may be achieved by the combined segment. 

(3)

The pro forma combined amounts are not necessarily indicative of what the results would have been had we acquired Cheminova on January 1, 2014 or indicative of future results.

FMC CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in millions)

September 30, 2015

December 31, 2014

Cash and cash equivalents

$

173.7

$

109.5

Trade receivables, net

1,689.6

1,602.5

Inventories

906.1

607.6

Other current assets

251.3

188.8

Deferred income taxes

158.1

222.7

Current assets held for sale

59.3

203.3

Total current assets

3,238.1

2,934.4

Property, plant and equipment, net

1,082.8

930.0

Goodwill

733.5

352.5

Other intangibles, net

847.7

246.9

Deferred income taxes

208.1

200.1

Other long-term assets

336.8

275.1

Noncurrent assets held for sale

—

401.5

Total assets

$

6,447.0

$

5,340.5

Short-term debt and current portion of long-term debt

$

121.2

$

525.2

Accounts payable, trade and other

484.2

378.3

Accrued customer rebates

357.3

236.0

Guarantees of vendor financing

65.7

50.2

Accrued pensions and other postretirement benefits, current

6.6

12.7

Other current liabilities

419.8

619.6

Current liabilities held for sale

0.2

88.4

Total current liabilities

1,455.0

1,910.4

Long-term debt

2,048.5

1,153.4

Long-term liabilities

788.9

708.0

Long-term liabilities held for sale

—

4.7

Equity

2,154.6

1,564.0

Total liabilities and equity

$

6,447.0

$

5,340.5

FMC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in millions)

Nine Months ended September 30

2015

2014

Cash provided (required) by operating activities of continuing operations ⁽¹⁾

$

(246.8)

$

132.4

Cash provided (required) by operating activities of discontinued operations

(63.7)

69.3

Cash provided (required) by investing activities of continuing operations

(1,281.7)

(167.8)

Cash provided (required) by investing activities of discontinued operations

1,634.3

168.4

Cash provided (required) by financing activities of continuing operations:

Increase (decrease) in short-term debt

(537.6)

(101.2)

Financing fees

—

(8.8)

Repayments of long-term debt

(1,024.4)

(17.7)

Proceeds from borrowings of long-term debt

1,650.1

—

Net distributions to and acquisitions of noncontrolling interests

—

(21.4)

Dividends paid

(64.3)

(58.1)

Other repurchases of common stock

(3.2)

(4.3)

Excess tax benefits from share-based compensation

1.6

4.4

Issuances of common stock, net

5.8

7.5

Cash provided (required) by financing activities

28.0

(199.6)

Effect of exchange rate changes on cash

(5.9)

(1.6)

Increase (decrease) in cash and cash equivalents

64.2

1.1

Cash and cash equivalents, beginning of year

109.5

123.2

Cash and cash equivalents, end of period

$

173.7

$

124.3

(1)

The nine months ended September 30, 2015 includes $264.8 million in payments associated with the Cheminova acquisition purchase price hedges and approximately $239 million in U.S. federal income tax payments principally driven by the sale of our Alkali Chemicals business.

Exhibit 99.2

Schedule of Adjusted Earnings From Continuing Operations (Non-GAAP) Recasting

As a global enterprise, our tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and reviews, and the impact of fluctuations in foreign currency remeasurement, as well as other discrete items. As a result, we can experience significant volatility in our tax provision as a result of factors unrelated to ongoing business operations. Management believes that excluding this volatility assists investors in understanding the Adjusted Earnings tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance. Historically, we have excluded most of these types of items for our Adjusted Earnings tax provision. However, we have not historically excluded the tax impact of fluctuations of foreign currency remeasurement. This remeasurement is primarily associated with U.S. dollar denominated monetary assets and liabilities of our foreign subsidiaries whose functional currency is the U.S. dollar. In these instances, changes in the exchange rate between the U.S. dollar and the statutory foreign currency give rise to a tax effect, even though there is no corresponding pre-tax exchange rate gain or loss in the remeasured financial statements. Significant volatility between the U.S dollar and the statutory foreign currency (most recently, for instance, the volatility in the Brazilian real) creates significant volatility in our GAAP tax provision. We will now be excluding the effect of these items from our adjusted earning tax provision for the reasons described herein.

Prospectively, we will exclude the GAAP tax provision, including all discrete items, from our Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the projected annual Non-GAAP effective tax rate. The difference between the GAAP tax provision and our Non-GAAP tax provision will be referred to as "Non-GAAP tax adjustments" and will be presented as a reconciling item within our Reconciliation of Net Income (Loss) attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, attributable to FMC Stockholders (Non-GAAP).

This Exhibit 99.2 provides the recasted quarterly periods of 2015 and 2014 to recast our Adjusted Earnings tax provision for the impacts of the foreign currency remeasurement and foreign currency discrete items. We are providing this information to assist investors and securities analysts in understanding the impact of this change on recent historical periods. The column labeled as "Adj." below provides the impact, each period, of this change on both the Adjusted Earnings tax provision and earnings per a share.

FMC CORPORATION
RECASTED - SCHEDULE OF ADJUSTED EARNINGS FROM CONTINUING OPERATIONS (NON-GAAP)
(Unaudited, in millions, except per share amounts)

2015

1Q

2Q

As filed

Adj.

Recasted

As filed

Adj.

Recasted

Revenue

$

659.4

$

—

$

659.4

$

887.1

$

—

$

887.1

Costs of sales and services

408.7

—

408.7

562.0

—

562.0

Gross margin

250.7

—

250.7

325.1

—

325.1

Selling, general and administrative expenses

101.0

—

101.0

126.8

—

126.8

Research and development expenses

26.6

—

26.6

39.0

—

39.0

Equity in (earnings) loss of affiliates

0.1

—

0.1

(0.1)

—

(0.1)

Total costs and expenses

536.4

—

536.4

727.7

—

727.7

Adjusted earnings from continuing operations, before interest, income taxes and noncontrolling interests ⁽¹⁾

$

123.0

$

—

$

123.0

$